{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:20Z","timestamp":1785414200872,"version":"3.56.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/aog.0b013e3182932f37","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T11:46:12Z","timestamp":1368013572000},"page":"1335-1347","source":"Crossref","is-referenced-by-count":45,"title":["Mifepristone\u2013Misoprostol Dosing Interval and Effect on Induction Abortion Times"],"prefix":"10.1097","volume":"121","author":[{"given":"Kate A.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J.","family":"Topp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-28-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2011.02.005","article-title":"Clinical guidelines. Labor induction abortion in the second trimester.","volume":"84","author":"Borgatta","year":"2011","journal-title":"Contraception"},{"issue":"suppl","key":"R3-28-20210126","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0968-8080(08)31385-8","article-title":"An historical overview of second trimester abortion methods.","volume":"16","author":"Bygdeman","year":"2008","journal-title":"Reprod Health Matters"},{"key":"R4-28-20210126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-0528.2003.00044.x-i1","article-title":"Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial.","volume":"111","author":"Grimes","year":"2004","journal-title":"BJOG"},{"key":"R5-28-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.1997.tb48523.x","article-title":"RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.","volume":"828","author":"Baulieu","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"R6-28-20210126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (mifepristone): mechanisms of action and clinical uses.","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu Rev Med"},{"key":"R7-28-20210126","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R8-28-20210126","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00404-011-1881-2","article-title":"Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.","volume":"283","author":"Goel","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R9-28-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tjog.2010.09.002","article-title":". Simultaneous use of mifepristone and misoprostol for early pregnancy termination.","volume":"50","author":"Li","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R10-28-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2007.05.088","article-title":"Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.","volume":"76","author":"Lohr","year":"2007","journal-title":"Contraception"},{"key":"R11-28-20210126","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":". Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.","volume":"117","author":"von Hertzen","year":"2010","journal-title":"BJOG"},{"key":"R12-28-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2006.01179.x","article-title":"Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.","volume":"114","author":"Guest","year":"2007","journal-title":"BJOG"},{"key":"R13-28-20210126","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2009.09.007","article-title":"Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.","volume":"81","author":"Wedisinghe","year":"2010","journal-title":"Contraception"},{"key":"R14-28-20210126","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/oxfordjournals.humrep.a137203","article-title":"The use of mifepristone prior to prostaglandin-induced mid-trimester abortion.","volume":"5","author":"Urquhart","year":"1990","journal-title":"Hum Reprod"},{"key":"R15-28-20210126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens.","volume":"10","author":"el-Refaey H, Templeton","year":"1995","journal-title":"Hum Reprod"},{"key":"R16-28-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0010-7824(96)00061-3","article-title":"Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.","volume":"53","author":"Ho","year":"1996","journal-title":"Contraception"},{"key":"R17-28-20210126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample.","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"R18-28-20210126","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/humrep\/dei216","article-title":"The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.","volume":"20","author":"Fiala","year":"2005","journal-title":"Hum Reprod"},{"key":"R19-28-20210126","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1996.tb09842.x","article-title":"A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol.","volume":"103","author":"Webster","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R20-28-20210126","first-page":"277","article-title":"Mifepristone and misoprostol in therapeutic abortions in French.","volume":"25","author":"Jannet","year":"1996","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"R21-28-20210126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0301-2115(00)00365-1","article-title":"Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristonemisoprostol to gemeprost.","volume":"95","author":"le Roux","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-28-20210126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/den425","article-title":". A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.","volume":"24","author":"Chai","year":"2009","journal-title":"Hum Reprod"},{"key":"R23-28-20210126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1472-6483(10)60522-6","article-title":"One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy.","volume":"8","author":"Heikinheimo","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"R24-28-20210126","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/der218","article-title":"One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancya randomized trial.","volume":"26","author":"Mentula","year":"2011","journal-title":"Hum Reprod"},{"key":"R25-28-20210126","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.06.008","article-title":"One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.","volume":"111","author":"Hou","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"R26-28-20210126","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/humrep\/15.10.2205","article-title":"Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy.","volume":"15","author":"Ngai","year":"2000","journal-title":"Hum Reprod"},{"key":"R27-28-20210126","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"key":"R28-28-20210126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e318227214e","article-title":". Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.","volume":"118","author":"Ngoc","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R29-28-20210126","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2010.03.006","article-title":"Comparison of two dose regimens of misoprostol for second-trimester pregnancy termination.","volume":"82","author":"Brouns","year":"2010","journal-title":"Contraception"},{"key":"R30-28-20210126","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s13224-011-0118-4","article-title":"Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy.","volume":"61","author":"Nagaria","year":"2011","journal-title":"J Obstet Gynaecol India"},{"key":"R31-28-20210126","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.","volume":"90","author":"Ho","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R32-28-20210126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14767050802283027","article-title":"Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.","volume":"21","author":"Jansen","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R33-28-20210126","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1471-0528.2002.01462.x","article-title":"A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.","volume":"109","author":"Bartley","year":"2002","journal-title":"BJOG"},{"key":"R34-28-20210126","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial.","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R35-28-20210126","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/00016340701505002","article-title":"One or two day mifepristone-misoprostol interval for second trimester abortion.","volume":"86","author":"Nilas","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R36-28-20210126","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1999.tb08371.x","article-title":"Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases.","volume":"106","author":"Ashok","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"R37-28-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases.","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"key":"R38-28-20210126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1479-828X.2009.01117.x","article-title":"Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort.","volume":"50","author":"Dickinson","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R39-28-20210126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.contraception.2005.12.004","article-title":"Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.","volume":"73","author":"Goh","year":"2006","journal-title":"Contraception"},{"key":"R40-28-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2009.10.001","article-title":". Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.","volume":"81","author":"Gomez","year":"2010","journal-title":"Contraception"},{"key":"R41-28-20210126","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3109\/00016349.2010.513427","article-title":"Clinical efficacy of mifepristone and misoprostol in second trimester pregnancy termination.","volume":"89","author":"Joensuu-Manninen","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R42-28-20210126","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/humrep\/dei037","article-title":"A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.","volume":"20","author":"Hamoda","year":"2005","journal-title":"Hum Reprod"},{"key":"R44-28-20210126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.contraception.2007.07.008","article-title":"Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination.","volume":"76","author":"Prairie","year":"2007","journal-title":"Contraception"},{"key":"R45-28-20210126","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B","article-title":"Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality).","volume":"19","author":"Mansfield","year":"1999","journal-title":"Prenat Diagn"},{"key":"R46-28-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejogrb.2010.04.004","article-title":"Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial.","volume":"151","author":"Hou","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0b013e3182932f37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:54:36Z","timestamp":1620946476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201306000-00028"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3182932f37","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}